{"id":"https://openalex.org/W40400135","doi":null,"title":"Improving non-nucleoside reverse transcriptase inhibitors for first-line treatment of HIV infection: the development pipeline and recent clinical data.","display_name":"Improving non-nucleoside reverse transcriptase inhibitors for first-line treatment of HIV infection: the development pipeline and recent clinical data.","alternate_titles":[],"publication_year":2008,"publication_date":"2008-07-01","ids":{"openalex":"https://openalex.org/W40400135","mag":"40400135","pmid":"https://pubmed.ncbi.nlm.nih.gov/18600563"},"language":"en","primary_location":{"id":"pmid:18600563","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18600563","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in drug discovery & development","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W40400135"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011016701","display_name":"Zachary K. Sweeney","orcid":"https://orcid.org/0000-0002-9852-1802","observed_orcids":["https://orcid.org/0000-0002-9852-1802"]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zachary K Sweeney","raw_affiliation_strings":["Department of Medicinal Chemistry, Roche Palo Alto, 3431 Hillview Avenue, Palo Alto, CA 94304, USA. zachary.sweeney@roche.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Roche Palo Alto, 3431 Hillview Avenue, Palo Alto, CA 94304, USA. zachary.sweeney@roche.com","institution_ids":["https://openalex.org/I129302853"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076998022","display_name":"Klaus Klumpp","orcid":"https://orcid.org/0000-0002-4829-3127","observed_orcids":["https://orcid.org/0000-0002-4829-3127"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Klaus Klumpp","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.1295,"has_fulltext":false,"cited_by_count":44,"citation_normalized_percentile":{"value":0.93758396,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"11","issue":"4","first_page":"458","last_page":"470"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-nucleoside-reverse-transcriptase-inhibitors","display_name":"non-nucleoside reverse transcriptase inhibitors","score":0.9909999966621399},{"id":"https://openalex.org/keywords/hiv-infection","display_name":"HIV infection","score":0.9290000200271606},{"id":"https://openalex.org/keywords/first-line-antiretroviral-therapy","display_name":"first-line antiretroviral therapy","score":0.9860000014305115},{"id":"https://openalex.org/keywords/rilpivirine","display_name":"rilpivirine","score":0.8830000162124634},{"id":"https://openalex.org/keywords/efavirenz","display_name":"efavirenz","score":0.8700000047683716},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.875},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.6230000257492065},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.5759999752044678},{"id":"https://openalex.org/keywords/drug-pipeline","display_name":"drug development pipeline","score":0.47200000286102295}],"concepts":[{"id":"https://openalex.org/C2781432083","wikidata":"https://www.wikidata.org/wiki/Q422645","display_name":"Efavirenz","level":5,"score":0.9072631597518921},{"id":"https://openalex.org/C2778723075","wikidata":"https://www.wikidata.org/wiki/Q421547","display_name":"Rilpivirine","level":5,"score":0.7205843329429626},{"id":"https://openalex.org/C156719811","wikidata":"https://www.wikidata.org/wiki/Q28774","display_name":"Reverse transcriptase","level":4,"score":0.6592228412628174},{"id":"https://openalex.org/C2777351918","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Reverse-transcriptase inhibitor","level":5,"score":0.6326853632926941},{"id":"https://openalex.org/C2779130552","wikidata":"https://www.wikidata.org/wiki/Q263713","display_name":"Nevirapine","level":5,"score":0.5915004014968872},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5555896759033203},{"id":"https://openalex.org/C2781143361","wikidata":"https://www.wikidata.org/wiki/Q55761529","display_name":"Protease inhibitor (pharmacology)","level":5,"score":0.5531845092773438},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.48421764373779297},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4605158567428589},{"id":"https://openalex.org/C2909970146","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Nucleoside Reverse Transcriptase Inhibitor","level":5,"score":0.4491425156593323},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.39707985520362854},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.385166198015213},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3736039698123932},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.2992519736289978},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.22587236762046814},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1964665949344635},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1869954764842987},{"id":"https://openalex.org/C49105822","wikidata":"https://www.wikidata.org/wiki/Q176996","display_name":"Polymerase chain reaction","level":3,"score":0.05831700563430786},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068696","descriptor_name":"Rilpivirine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010721","descriptor_name":"Phosphinic Acids","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010721","descriptor_name":"Phosphinic Acids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010721","descriptor_name":"Phosphinic Acids","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:18600563","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18600563","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in drug discovery & development","raw_type":"Journal Article"},{"id":"mag:40400135","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18600563","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2164020980","https://openalex.org/W2094754615","https://openalex.org/W2080263136","https://openalex.org/W2168926375","https://openalex.org/W2976245304","https://openalex.org/W1965664889","https://openalex.org/W2396989952","https://openalex.org/W2160557134","https://openalex.org/W2349926682","https://openalex.org/W2342950203"],"abstract_inverted_index":{"Efavirenz":[0],"non-nucleoside":[1],"reverse":[2],"transcriptase":[3],"inhibitor":[4,10],"(NNRTI)-based":[5],"therapy":[6,12,28],"or":[7],"boosted":[8],"protease":[9],"(PI)-based":[11],"are":[13,30,80,166,183,194],"currently":[14,195],"recommended":[15],"as":[16,185,187],"first-line":[17,111,151],"regimens":[18,58,79],"for":[19,110,150,180],"the":[20,26,35,52,173,188,191],"treatment":[21,39,148],"of":[22,37,54,122,155,176,190],"HIV":[23],"infection.":[24],"Although":[25],"available":[27],"options":[29,149],"efficacious":[31],"and":[32,51,67,75,90,98,118,136,145],"well-tolerated":[33],"in":[34,128,196],"majority":[36],"patients,":[38],"durability":[40],"is":[41],"still":[42,107],"limited":[43],"by":[44],"drug-related":[45],"side":[46,73,102],"effects,":[47],"inadequate":[48],"patient":[49,116],"adherence":[50,117],"development":[53,129],"drug":[55,65],"resistance.":[56],"PI-based":[57],"have":[59,68,83,91],"higher":[60],"tablet":[61],"loads,":[62],"more":[63],"complicated":[64],"interactions":[66],"been":[69,92],"associated":[70,93],"with":[71,94],"gastrointestinal":[72],"effects":[74],"metabolic":[76],"abnormalities.":[77],"NNRTI-based":[78],"efficacious,":[81],"but":[82],"a":[84,108,177],"low":[85],"genetic":[86],"barrier":[87],"to":[88],"resistance":[89],"rash,":[95],"hypersensitivity":[96],"reactions":[97],"central":[99],"nervous":[100],"system":[101],"effects.":[103],"There":[104],"is,":[105],"therefore,":[106],"need":[109],"antiviral":[112],"agents":[113],"that":[114,160,193],"facilitate":[115],"allow":[119],"durable":[120],"suppression":[121],"viral":[123],"replication.":[124],"The":[125],"next-generation":[126,178],"NNRTIs":[127,139,192],"include":[130],"rilpivirine":[131],"(TMC-278),":[132],"UK-453061,":[133],"RDEA-806,":[134],"IDX-899":[135],"MK-4965.":[137],"These":[138],"demonstrate":[140],"significant":[141],"advantages":[142],"over":[143],"efavirenz,":[144],"may":[146],"improve":[147],"therapy.":[152],"A":[153],"number":[154],"other":[156],"structurally":[157],"diverse":[158],"compounds":[159],"inhibit":[161],"common":[162],"NNRTI-resistant":[163],"mutant":[164],"viruses":[165],"also":[167],"under":[168],"investigation.":[169],"In":[170],"this":[171],"review,":[172],"desirable":[174],"features":[175],"NNRTI":[179],"treatment-na\u00efve":[181],"patients":[182],"discussed,":[184],"well":[186],"properties":[189],"development.":[197]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W40400135","counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
